Latest News and Press Releases
Want to stay updated on the latest news?
-
MIGDAL HA'EMEQ, Israel, June 06, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today...
-
MIGDAL HA'EMEQ, Israel, May 25, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today...
-
MIGDAL HA'EMEQ, Israel, May 17, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today...
-
MIGDAL HA'EMEQ, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based...
-
LAVAL, Québec and MIGDAL HA’EMEQ, Israel, April 03, 2017 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. (“Neptune”) (NASDAQ:NEPT) (TSX:NEPT) and Enzymotec Ltd., Enzymotec...
-
MIGDAL HA'EMEQ, Israel, March 16, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active...
-
MIGDAL HA’EMEQ, Israel, March 10, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (the “Company”), today announced that it will hold an Extraordinary General Meeting of Shareholders (the...
-
MIGDAL HA'EMEQ, Israel, March 09, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
-
MIGDAL HA'EMEQ, Israel, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today...
-
$2.0 million inventory write-off impacts GAAP and non-GAAP EPS by ($0.09) $0.9 million bad debt provision impacts GAAP EPS by ($0.04) MIGDAL HA'EMEQ, Israel, Feb. 06, 2017 (GLOBE NEWSWIRE) --...